Clinical trial
Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial…
NCT00408473 · MEDA Pharma GmbH & Co. KG, Industry · Terminated
Key facts
| NCT number | NCT00408473 |
|---|---|
| Title | Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation. |
| Official title | A Randomised Double-blind Pilot Study Comparing Flecainide CR and Placebo in the Early Treatment of Patients With a Documented First Episode of Atrial Fibrillation. |
| Lead sponsor | MEDA Pharma GmbH & Co. KG, Industry |
| Collaborators | 3M Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Flecainide |
| Enrollment | 256 |
| First posted | Dec 7, 2006 |
| Last update posted | Feb 7, 2022 |
| Countries | Belgium, Bulgaria, France, Germany, Netherlands, Romania, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: